JEFFREY PIERCE: Open Payments
NPI 1245982875 · CROCKETT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$194 in 10 payments from 7 companies in 2025. Trend: 2023 $271 · 2024 $271 · 2025 $194
Food & beverage: $194
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $53 |
| PFIZER INC. | 2 | $53 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| Novo Nordisk Inc | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: OTEZLA, ELIQUIS, BREZTRI, TRELEGY ELLIPTA, RELISTOR, Wegovy, JARDIANCE.
Industry payments across TX — which companies pay providers there.
